HIV Medicine

Journal

Publication Venue For

  • Cause of death among HIV patients in London in 2016.  20:628-633. 2019
  • Antiretroviral pill count and clinical outcomes in treatment-na├»ve patients with HIV infection.  19:132-142. 2018
  • Infection-related and -unrelated malignancies, HIV and the aging population.  17:590-600. 2016
  • Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.  16:572-577. 2015
  • Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe.  16:544-552. 2015
  • Pharmacokinetics of tenofovir during pregnancy and postpartum.  16:502-511. 2015
  • Are neighborhood conditions associated with HIV management?.  14:624-632. 2013
  • The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: Collaborative cohort analysis.  13:89-97. 2012
  • British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.  12:517-524. 2011
  • 3 Pulmonary opportunistic infections.  12:25-42. 2011
  • 9 Pyrexia of unknown origin (PUO).  12:83-87. 2011
  • British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011..  12 Suppl 2:1-140. 2011
  • 12 Intensive care.  12:109-111. 2011
  • Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.  11:462-468. 2010
  • Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.  11:379-388. 2010
  • Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.  11:276-281. 2010
  • Immunosuppression among HIV-1-positive patients attending for care: Experience from two large HIV centres in the United Kingdom.  11:114-120. 2010
  • Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.  10:439-446. 2009
  • Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.  10:343-350. 2009
  • Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.  7:437-441. 2006
  • Erratum: Knowledge, attitudes and health outcomes in HIV-infected travellers to the USA (HIV Medicine (2006) vol. 7 (201-204)).  7:345. 2006
  • Knowledge, attitudes and health outcomes in HIV-infected travellers to the USA.  7:201-204. 2006
  • BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.  6:62-83. 2005
  • Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.  4:235-240. 2003
  • International Standard Serial Number (issn)

  • 1464-2662
  • Electronic International Standard Serial Number (eissn)

  • 1468-1293